PL1865961T3 - Famciklowir do leczenia nawracającej opryszczki wargowej z zastosowaniem leczenia jednodniowego - Google Patents
Famciklowir do leczenia nawracającej opryszczki wargowej z zastosowaniem leczenia jednodniowegoInfo
- Publication number
- PL1865961T3 PL1865961T3 PL06739956T PL06739956T PL1865961T3 PL 1865961 T3 PL1865961 T3 PL 1865961T3 PL 06739956 T PL06739956 T PL 06739956T PL 06739956 T PL06739956 T PL 06739956T PL 1865961 T3 PL1865961 T3 PL 1865961T3
- Authority
- PL
- Poland
- Prior art keywords
- treatment
- famciclovir
- herpes labialis
- recurrent herpes
- day
- Prior art date
Links
- 208000004898 Herpes Labialis Diseases 0.000 title abstract 2
- 206010067152 Oral herpes Diseases 0.000 title abstract 2
- 229960004396 famciclovir Drugs 0.000 title abstract 2
- GGXKWVWZWMLJEH-UHFFFAOYSA-N famcyclovir Chemical compound N1=C(N)N=C2N(CCC(COC(=O)C)COC(C)=O)C=NC2=C1 GGXKWVWZWMLJEH-UHFFFAOYSA-N 0.000 title abstract 2
- 230000000306 recurrent effect Effects 0.000 title abstract 2
- 241000124008 Mammalia Species 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- JNTOCHDNEULJHD-UHFFFAOYSA-N Penciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(CCC(CO)CO)C=N2 JNTOCHDNEULJHD-UHFFFAOYSA-N 0.000 abstract 1
- 229960001179 penciclovir Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US66653605P | 2005-03-30 | 2005-03-30 | |
| PCT/US2006/011498 WO2006105216A1 (en) | 2005-03-30 | 2006-03-29 | Famciclovir for the treatment of recurrent herpes labialis using a one-day treatment |
| EP06739956A EP1865961B1 (en) | 2005-03-30 | 2006-03-29 | Famciclovir for the treatment of recurrent herpes labialis using a one-day treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1865961T3 true PL1865961T3 (pl) | 2012-07-31 |
Family
ID=36829888
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL06739956T PL1865961T3 (pl) | 2005-03-30 | 2006-03-29 | Famciklowir do leczenia nawracającej opryszczki wargowej z zastosowaniem leczenia jednodniowego |
Country Status (15)
| Country | Link |
|---|---|
| US (4) | US20100298353A1 (https=) |
| EP (2) | EP2363131A1 (https=) |
| JP (3) | JP2008534603A (https=) |
| KR (1) | KR101312820B1 (https=) |
| CN (1) | CN101678028A (https=) |
| AT (1) | ATE545419T1 (https=) |
| AU (3) | AU2006230269A1 (https=) |
| BR (1) | BRPI0609793A2 (https=) |
| CA (1) | CA2602641A1 (https=) |
| ES (1) | ES2382664T3 (https=) |
| PL (1) | PL1865961T3 (https=) |
| PT (1) | PT1865961E (https=) |
| RU (2) | RU2007139762A (https=) |
| TW (1) | TW200716124A (https=) |
| WO (1) | WO2006105194A2 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2006230269A1 (en) * | 2005-03-30 | 2006-10-05 | Novartis Ag | Penciclovir or famciclovir for the treatment of recurrent genital herpes with a one-day application |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3485225D1 (de) | 1983-08-18 | 1991-12-05 | Beecham Group Plc | Antivirale guanin-derivate. |
| EP0182024B1 (en) | 1984-09-20 | 1991-04-03 | Beecham Group Plc | Purine derivatives and their pharmaceutical use |
| EP0216459B1 (en) | 1985-07-27 | 1990-05-16 | Beecham Group Plc | 9-substituted guanine monohydrates |
| GB8628826D0 (en) | 1986-12-02 | 1987-01-07 | Beecham Group Plc | Pharmaceutical products |
| US5840763A (en) * | 1994-12-12 | 1998-11-24 | Smithkline Beecham Plc | Treatment of a latent infection of herpes viruses |
| RU2179849C2 (ru) * | 1999-07-27 | 2002-02-27 | Уральский научно-исследовательский институт дерматовенерологии и иммунопатологии | Способ лечения рецидивирующего генитального герпеса у женщин |
| RU2178699C1 (ru) * | 2001-04-04 | 2002-01-27 | Змызгова Анна Васильевна | Способ лечения герпесовирусных инфекций, включающий озонотерапию |
| AU2006230269A1 (en) * | 2005-03-30 | 2006-10-05 | Novartis Ag | Penciclovir or famciclovir for the treatment of recurrent genital herpes with a one-day application |
-
2006
- 2006-03-28 AU AU2006230269A patent/AU2006230269A1/en not_active Abandoned
- 2006-03-29 AT AT06739956T patent/ATE545419T1/de active
- 2006-03-29 BR BRPI0609793-6A patent/BRPI0609793A2/pt not_active IP Right Cessation
- 2006-03-29 KR KR1020077024918A patent/KR101312820B1/ko not_active Expired - Fee Related
- 2006-03-29 EP EP10179668A patent/EP2363131A1/en not_active Withdrawn
- 2006-03-29 EP EP06739956A patent/EP1865961B1/en not_active Expired - Lifetime
- 2006-03-29 PL PL06739956T patent/PL1865961T3/pl unknown
- 2006-03-29 PT PT06739956T patent/PT1865961E/pt unknown
- 2006-03-29 RU RU2007139762/14A patent/RU2007139762A/ru unknown
- 2006-03-29 TW TW095110943A patent/TW200716124A/zh unknown
- 2006-03-29 CN CN200680010840A patent/CN101678028A/zh active Pending
- 2006-03-29 CA CA002602641A patent/CA2602641A1/en not_active Abandoned
- 2006-03-29 RU RU2007139758/15A patent/RU2432951C2/ru active
- 2006-03-29 WO PCT/US2006/011460 patent/WO2006105194A2/en not_active Ceased
- 2006-03-29 ES ES06739956T patent/ES2382664T3/es not_active Expired - Lifetime
- 2006-03-29 AU AU2006230291A patent/AU2006230291A1/en not_active Abandoned
- 2006-03-29 JP JP2008504316A patent/JP2008534603A/ja not_active Withdrawn
-
2010
- 2010-05-06 AU AU2010201834A patent/AU2010201834B2/en not_active Expired - Fee Related
- 2010-07-01 US US12/803,649 patent/US20100298353A1/en not_active Abandoned
-
2011
- 2011-12-20 US US13/330,979 patent/US20120088781A1/en not_active Abandoned
-
2012
- 2012-09-06 US US13/604,955 patent/US20120329814A1/en not_active Abandoned
- 2012-10-19 JP JP2012232172A patent/JP6018473B2/ja not_active Expired - Fee Related
-
2014
- 2014-04-14 US US14/252,514 patent/US20150005324A1/en not_active Abandoned
-
2015
- 2015-04-01 JP JP2015075416A patent/JP2015163614A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| RU2007139758A (ru) | 2009-05-10 |
| AU2006230269A1 (en) | 2006-10-05 |
| ATE545419T1 (de) | 2012-03-15 |
| JP2013049687A (ja) | 2013-03-14 |
| US20120329814A1 (en) | 2012-12-27 |
| JP2015163614A (ja) | 2015-09-10 |
| EP2363131A1 (en) | 2011-09-07 |
| BRPI0609793A2 (pt) | 2010-04-27 |
| AU2010201834A1 (en) | 2010-05-27 |
| RU2432951C2 (ru) | 2011-11-10 |
| KR101312820B1 (ko) | 2013-09-27 |
| RU2007139762A (ru) | 2009-05-10 |
| US20120088781A1 (en) | 2012-04-12 |
| EP1865961B1 (en) | 2012-02-15 |
| AU2006230291A1 (en) | 2006-10-05 |
| JP6018473B2 (ja) | 2016-11-02 |
| CA2602641A1 (en) | 2006-10-05 |
| ES2382664T3 (es) | 2012-06-12 |
| US20100298353A1 (en) | 2010-11-25 |
| KR20080004535A (ko) | 2008-01-09 |
| AU2006230291A8 (en) | 2013-10-24 |
| AU2010201834B2 (en) | 2012-04-19 |
| PT1865961E (pt) | 2012-05-22 |
| WO2006105194A2 (en) | 2006-10-05 |
| CN101678028A (zh) | 2010-03-24 |
| WO2006105194A3 (en) | 2006-12-21 |
| US20150005324A1 (en) | 2015-01-01 |
| TW200716124A (en) | 2007-05-01 |
| EP1865961A1 (en) | 2007-12-19 |
| JP2008534603A (ja) | 2008-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI7594U1 (fi) | Absorptiokappale kiinitettäväksi ihmiskehoon | |
| SI1613350T1 (sl) | Zdravljenje avtoimunske bolezni pri bolniku z neustreznim odzivom na inhibitor TNF-alfa | |
| CY1112281T1 (el) | Αναστολεις διπεπτιδυλ πεπτιδασης για τη θεραπεια του διαβητη | |
| WO2008043052A3 (en) | Human antibodies neutralizing human metapneumovirus | |
| WO2005053607A3 (en) | Method for preventing hepatic encephalopathic episodes | |
| NZ577393A (en) | Use of 3-alpha-androstanediol, optionally in combination with a pde5 inhibitor, in the treatment of sexual dysfunction | |
| WO2006138709A3 (en) | Lkktet and/or lkktnt peptide compositions and methods | |
| WO2006128022A3 (en) | Solid compositions and methods for treating middle-of-the night insomnia | |
| PL1900362T3 (pl) | Pochodne alfa-aminoamidu użyteczne w leczeniu zaburzeń uzależnieniowych | |
| WO2006130433A3 (en) | Treatment of ischemia using stem cells | |
| WO2005011590A3 (en) | Compositions and methods for restoring sensitivity to treatment with her2 antagonists | |
| WO2007109093A3 (en) | Pyrazolo[1,5-a]pyrimidine derivatives and methods of use thereof | |
| WO2006033795A3 (en) | Substituted pyrazolo [1, 5-a] pyrimidines for inhibiting abnormal cell growth | |
| WO2006110724A3 (en) | Method of treating schizophrenia prodrome | |
| AR058173A1 (es) | Uso de sdf-1 para el tratamiento y/o prevencion de enfermedades neurologicas | |
| PL1954281T3 (pl) | Sposób leczenia raka | |
| BRPI0408500A (pt) | tratamento do diabetes do tipo 1 com inibidores de pde5 | |
| PL1865961T3 (pl) | Famciklowir do leczenia nawracającej opryszczki wargowej z zastosowaniem leczenia jednodniowego | |
| PL1891961T3 (pl) | Zastosowanie 5'-metylotioadenozyny (mta) w zapobieganiu i/lub leczeniu chorób autoimmunologicznych i/lub odrzucania przeszczepu | |
| TW200742580A (en) | Methods for treating nephrolithiasis | |
| SI1362590T1 (sl) | Uporaba ciklobradina ali njegovih farmacevtsko sprejemljivih soli za zdravljenje ali preprečevanje | |
| WO2005077356A3 (en) | Glycine and/or for use in cartilage affecting conditions | |
| EP1949903B8 (en) | Selective a2a receptor antagonists for the treatment of auricular fibrillation | |
| UY29532A1 (es) | Derivados del ácido 6,7-dihidro-5h-imidazo(1,2-a)imidazol-3-sulfónico | |
| AU2003244978A8 (en) | Methods to identify anti-tumoral agents inhibiting rasgap / aurora kinase interactions |